Product Details
| Cat.No. | EDC00313 | Product Name | OCI-Aml-3 |
|---|---|---|---|
| Species | Human | Cellosaurus ID | CVCL_1844 |
| Cell Name | OCI-AML-3 | Cell Line Synonyms | OCI-Aml-3, OCI/AML-3, OCI-AML3, OCI/AML3, OCI AML3, OCIAML3, Ontario Cancer Institute-Acute Myeloid Leukemia-3 |
| Digestion Time | / | Morphology | Suspension |
| Passage Ratio | 1:2~1:3 | Complete Culture Medium | RPMI-1640+20% FBS |
| Freezing Medium | 90% FBS+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
STR Profile
| Loci | STR Info (Sample Cell) Sample Cell Line: OCI-AML-3 | STR Info (Cell bank) Cell Line: OCI-AML-3 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 11 | 12 | 11 | 12 |
| D2S1338 | 17 | 21 | 17 | 21 |
| D3S1358 | 16 | 16 | ||
| D5S818 | 11 | 13 | 11 | 13 |
| D7S820 | 9 | 10 | 9 | 10 |
| D8S1179 | 10 | 12 | 10 | 12 |
| D13S317 | 8 | 13 | 8 | 13 |
| D16S539 | 11 | 13 | 11 | 13 |
| D18S51 | 12 | 18 | 12 | 18 |
| D19S433 | 15 | 17 | 15 | 17 |
| D21S11 | 29 | 30 | 29 | 30 |
| FGA | 22 | 22 | ||
| Penta D | 12 | 13 | 12 | 13 |
| Penta E | 11 | 13 | 11 | 13 |
| TH01 | 8 | 10 | 8 | 10 |
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 17 | 18 | 17 | 18 |
| D6S1043 | 11 | 13 | ||
| D12S391 | 20 | 21 | ||
| D2S441 | 14 | |||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
